Skip to main content
. 2015 Jul 23;6(28):25109–25120. doi: 10.18632/oncotarget.4668

Table 4. Cox regression of overall survival in aberrant AML karyotype.

Covariates HR 95% CI p-Value
Age 1.04 1.001 – 1.086 0.046
Risk group
  • *Aberrant K-intermediate riska 1.49 0.77 – 2.87 0.235
  • *Aberrant K-high riska 2.46 0.92 – 6.58 0.073
TERT rs2853669 C/Tb 1.22 0.75 – 2 0.409
TERT rs2853669 C/Cb 0.8 0.22 – 2.89 0.736
Treatmentc 0.34 0.1 – 1.16 0.086
a

Compared to low risk

b

Compared to T/T

c

Chemo + allo-SCT compared to chemo only